MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
ENDRA Life Sciences ROCE Ratio 2011-2026 | NDRA
Annual ROCE Ratio ENDRA Life Sciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -185.74 | -281.17 | -179.81 | -173.8 | -106.62 | -147.87 | -212.47 | -139.74 | -87.69 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -87.69 | -281.17 | -168.32 |
Quarterly ROCE Ratio ENDRA Life Sciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -232.5 | -139.26 | -105.48 | -121.41 | -154.46 | -212.05 | -187.51 | -57.59 | -91.08 | -66.98 | -93.77 | -91.76 | -111.91 | -98.57 | -93.13 | -55.7 | -97.46 | -119.06 | -134.71 | -120.12 | -171.86 | -181.85 | -190.41 | -151.13 | -188.83 | -174.79 | -158.41 | -112.29 | -129.56 | -109.13 | -99.98 | -44.14 | 23.57 | 108.54 | 183.88 | 164.79 | 164.79 | 97.09 | 41.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 183.88 | -232.5 | -84.93 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 116.83 | 2.6 % | $ 35.5 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 25.13 | 1.19 % | $ 698 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Danaher Corporation
DHR
|
8.93 | $ 196.66 | 2.95 % | $ 140 B | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 18.02 | 1.98 % | $ 960 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
33.2 | $ 65.77 | 4.21 % | $ 25.7 B | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.25 | 2.14 % | $ 491 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 15.84 | -1.55 % | $ 170 M |  China |
 |
Guardant Health
GH
|
440.3 | $ 94.49 | 1.28 % | $ 11.8 B | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 176.18 | 3.87 % | $ 8.73 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
-41.6 | $ 14.28 | -1.72 % | $ 1.85 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 108.06 | 0.84 % | $ 8.91 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.99 | -0.25 % | $ 8.8 M | USA |
 |
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 128.36 | 1.52 % | $ 20.4 B | USA |
 |
PerkinElmer
PKI
|
4.92 | - | -0.91 % | $ 14.7 B | USA |
 |
IQVIA Holdings
IQV
|
33.55 | $ 174.45 | 2.3 % | $ 30 B | USA |
 |
Quotient Limited
QTNT
|
232.42 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 275.15 | 2.22 % | $ 22.9 B | USA |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.66 | -1.3 % | $ 86.3 K | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 80.09 | 2.57 % | $ 5.41 B | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.16 | - | $ 4.96 M | USA |
 |
BioNano Genomics
BNGO
|
-75.05 | $ 1.17 | 0.02 % | $ 6.37 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | Israel |
 |
Medpace Holdings
MEDP
|
116.53 | $ 523.59 | 2.96 % | $ 15.1 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 323.64 | 4.22 % | $ 27.3 B | Schweiz |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 4.86 | 2.43 % | $ 450 M | USA |
 |
Celcuity
CELC
|
-171.24 | $ 116.44 | 0.76 % | $ 5.44 B | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.3 | 2.98 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 10.53 | 5.46 % | $ 2.28 B | USA |
 |
Natera
NTRA
|
-76.66 | $ 211.61 | 1.12 % | $ 20.8 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.63 | 3.43 % | $ 395 M | USA |